Cite
HARVARD Citation
Park, S. et al. (2021). Angiotensin-Converting Enzyme Inhibitor–based Versus Angiotensin Receptor Blocker–based Optimal Medical Therapy After Percutaneous Coronary Intervention. Journal of cardiovascular pharmacology. 77 (1), p. . [Online].